Table: SymBio Pharmaceuticals -Q1 parent results

SymBio Pharmaceuticals

10/05/2016 07:30

May 10 (Reuters)-  
             SymBio Pharmaceuticals Limited  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended        Year to   
                Mar 31, 2016        Mar 31, 2015      Dec 31, 2016   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            193 mln             408 mln            2.34       
                 (-52.7 pct)        (+135.0 pct)       (+21.0 pct)   
  Operating     loss 518 mln        loss 332 mln        loss 2.78    
  Recurring     loss 655 mln        loss 418 mln        loss 2.81    
  Net           loss 652 mln        loss 420 mln        loss 2.82    
  EPS          loss 20.15 yen      loss 12.98 yen    loss 83.22 yen  
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T 
  ((Tokyo Headline News Desk +813 6441 1812))